High bone marrow fat in patients with Cushing’s syndrome and vertebral fractures

Abstract

Purpose The evaluation of skeletal fragility in Cushing’s syndrome (CS) is a clinical challenge, since dual-energy X-ray absorptiometry (DXA) does not capture abnormalities in bone microstructure induced by glucocorticoid excess. Hypercortisolism was shown to increase bone marrow adiposity, but it is still unknown whether high bone marrow fat (BMF) as measured by vertebral magnetic resonance spectroscopy may predict fracture risk in this clinical setting. In this cross-sectional study, we evaluated the association between BMF and vertebral fractures (VFs) in patients with CS. Methods Twenty patients (5 M, age 44\u2009±\u200913 years) with active CS were evaluated for morphometric VFs, lumbar spine BMF, and bone mineral density (BMD). Fifteen healthy volunteers (4\u2009M, age 43\u2009±\u200912 years) acted as control group for BMF evaluation. Results BMF was significantly higher in CS patients vs. controls (52.0% vs. 27.0%, p \u2009<\u20090.01), and was directly correlated with patients’ age ( p \u2009=\u20090.03), 24-hours urine-free cortisol ( p \u2009=\u20090.03), midnight serum cortisol ( p \u2009=\u20090.02), and serum CTX ( p \u2009=\u20090.01). Patients with VFs (13 cases) showed significantly higher BMF vs. patients without VFs (65.0% vs. 24.0%, p \u2009=\u20090.03). Fractured patients with either normal BMD or osteopenia showed comparable BMF to fractured patients with either osteoporosis or low BMD for age ( p \u2009=\u20090.71). When the analysis was restricted to patients with normal BMD or osteopenia, VFs were still significantly associated with higher BMF ( p \u2009=\u20090.05). Conclusions This study provides a first evidence that vertebral adiposity may be a marker of hypercortisolism-induced skeletal fragility and measurement of spine BMF could have a role in the diagnostic work-up for the assessment of fracture risk in CS.